T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Dolby
DLB
$6.8B
| $15M | ﹤0.01% |
195,615
+141,593
| +262% | +$10.8M |
|
1052
WEX
WEX
$5.81B
| $14.9M | ﹤0.01% |
70,987
-1,251
| -2% | -$262K |
|
1053
Teva Pharmaceuticals
TEVA
$22.8B
| $14.9M | ﹤0.01% |
825,431
+571,302
| +225% | +$10.3M |
|
1054
Freshpet
FRPT
$2.6B
| $14.9M | ﹤0.01% |
108,708
-462,322
| -81% | -$63.2M |
|
1055
Tapestry
TPR
$22.2B
| $14.9M | ﹤0.01% |
316,151
+5,364
| +2% | +$252K |
|
1056
Vital Farms
VITL
$2.1B
| $14.8M | ﹤0.01% |
422,622
+409,762
| +3,186% | +$14.4M |
|
1057
EPR Properties
EPR
$4.31B
| $14.6M | ﹤0.01% |
298,513
+232,330
| +351% | +$11.4M |
|
1058
Illumina
ILMN
$14.7B
| $14.6M | ﹤0.01% |
112,068
-584
| -0.5% | -$76.2K |
|
1059
Toll Brothers
TOL
$13.8B
| $14.6M | ﹤0.01% |
94,299
+10,324
| +12% | +$1.6M |
|
1060
Henry Schein
HSIC
$8.43B
| $14.5M | ﹤0.01% |
198,983
+87
| +0% | +$6.34K |
|
1061
Amicus Therapeutics
FOLD
$2.45B
| $14.3M | ﹤0.01% |
1,341,921
-48,126
| -3% | -$514K |
|
1062
Workiva
WK
$4.24B
| $14.2M | ﹤0.01% |
179,552
-215,749
| -55% | -$17.1M |
|
1063
BWX Technologies
BWXT
$15.5B
| $14.2M | ﹤0.01% |
130,235
+4,187
| +3% | +$455K |
|
|
OS
1064
OneStream, Inc. Class A Common Stock
OS
$3.6B
| $14.1M | ﹤0.01% |
+415,521
| New | +$14.1M |
|
1065
Affiliated Managers Group
AMG
$6.6B
| $14.1M | ﹤0.01% |
79,217
+2,837
| +4% | +$504K |
|
1066
Match Group
MTCH
$9.15B
| $14M | ﹤0.01% |
370,937
-14,788
| -4% | -$560K |
|
1067
MGM Resorts International
MGM
$9.62B
| $14M | ﹤0.01% |
357,174
-184,274
| -34% | -$7.2M |
|
|
AUTL
1068
Autolus Therapeutics
AUTL
$381M
| $13.9M | ﹤0.01% |
3,841,502
-572,585
| -13% | -$2.08M |
|
1069
Solventum
SOLV
$12.3B
| $13.9M | ﹤0.01% |
199,772
-292
| -0.1% | -$20.4K |
|
1070
Novartis
NVS
$247B
| $13.9M | ﹤0.01% |
120,721
+113,634
| +1,603% | +$13.1M |
|
1071
Avantor
AVTR
$8.6B
| $13.9M | ﹤0.01% |
536,731
-12,545
| -2% | -$325K |
|
1072
First Advantage
FA
$2.74B
| $13.9M | ﹤0.01% |
699,447
+683,139
| +4,189% | +$13.6M |
|
1073
Pinnacle West Capital
PNW
$10.6B
| $13.8M | ﹤0.01% |
156,029
+1,000
| +0.6% | +$88.6K |
|
1074
Impinj
PI
$5.34B
| $13.8M | ﹤0.01% |
63,538
+48,771
| +330% | +$10.6M |
|
1075
Hasbro
HAS
$10.9B
| $13.7M | ﹤0.01% |
189,840
+1,467
| +0.8% | +$106K |
|